Literature DB >> 20478541

Helicobacter pylori exploits host membrane phosphatidylserine for delivery, localization, and pathophysiological action of the CagA oncoprotein.

Naoko Murata-Kamiya1, Kenji Kikuchi, Takeru Hayashi, Hideaki Higashi, Masanori Hatakeyama.   

Abstract

When delivered into gastric epithelial cells via type IV secretion, Helicobacter pylori CagA perturbs host cell signaling and thereby promotes gastric carcinogenesis. However, the mechanisms of CagA delivery, localization, and action remain poorly understood. We show that direct contact of H. pylori with epithelial cells induces externalization of the inner leaflet enriched host phospholipid, phosphatidylserine, to the outer leaflet of the host plasma membrane. CagA, which is exposed on the bacterial surface via type IV secretion, interacts with the externalized phosphatidylserine to initiate its entry into cells. CagA delivery also requires energy-dependent host cell processes distinct from known endocytic pathways. Within polarized epithelial cells, CagA is tethered to the inner leaflet of the plasma membrane through interaction with phosphatidylserine and binds the polarity-regulating host kinase PAR1/MARK to induce junctional and polarity defects. Thus, host membrane phosphatidylserine plays a key role in the delivery, localization, and pathophysiological action of CagA. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20478541     DOI: 10.1016/j.chom.2010.04.005

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  71 in total

1.  A novel inhibitory domain of Helicobacter pylori protein CagA reduces CagA effects on host cell biology.

Authors:  Christiane Pelz; Sylvia Steininger; Claudia Weiss; Fabian Coscia; Roger Vogelmann
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

2.  The coupling protein Cagbeta and its interaction partner CagZ are required for type IV secretion of the Helicobacter pylori CagA protein.

Authors:  Angela Jurik; Elisabeth Hausser; Stefan Kutter; Isabelle Pattis; Sandra Prassl; Evelyn Weiss; Wolfgang Fischer
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

3.  Attenuated CagA oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon.

Authors:  Masato Suzuki; Kotaro Kiga; Dangeruta Kersulyte; Jaime Cok; Catherine C Hooper; Hitomi Mimuro; Takahito Sanada; Shiho Suzuki; Masaaki Oyama; Hiroko Kozuka-Hata; Shigeru Kamiya; Quan-Ming Zou; Robert H Gilman; Douglas E Berg; Chihiro Sasakawa
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

4.  Potentiation of Helicobacter pylori CagA protein virulence through homodimerization.

Authors:  Lisa Nagase; Naoko Murata-Kamiya; Masanori Hatakeyama
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

Review 5.  Role of Helicobacter pylori infection in pathogenesis of gastric carcinoma.

Authors:  Rong-Guang Zhang; Guang-Cai Duan; Qing-Tang Fan; Shuai-Yin Chen
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 6.  Role of Helicobacter pylori in gastric cancer: Updates.

Authors:  Jahanarah Khatoon; Ravi Prakash Rai; Kashi Nath Prasad
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

Review 7.  Manipulation of host membranes by bacterial effectors.

Authors:  Hyeilin Ham; Anju Sreelatha; Kim Orth
Journal:  Nat Rev Microbiol       Date:  2011-07-18       Impact factor: 60.633

Review 8.  Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease.

Authors:  Dacie R Bridge; D Scott Merrell
Journal:  Gut Microbes       Date:  2013-02-04

Review 9.  Helicobacter pylori CagA: a critical destroyer of the gastric epithelial barrier.

Authors:  Jia Wu; Song Xu; Yongliang Zhu
Journal:  Dig Dis Sci       Date:  2013-02-20       Impact factor: 3.199

10.  Structural insights into Helicobacter pylori oncoprotein CagA interaction with β1 integrin.

Authors:  Burcu Kaplan-Türköz; Luisa F Jiménez-Soto; Cyril Dian; Claudia Ertl; Han Remaut; Arthur Louche; Tommaso Tosi; Rainer Haas; Laurent Terradot
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.